Do iodinated contrast agents impair fibrinolysis in acute stroke? A systematic review

American Journal of Neuroradiology

Volumn 31, Issue 1, 2010, Pages 170-174

  Dani, K A ^a   Muir, Keith W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED CONTRAST MEDIUM;

ACUTE DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; META ANALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; REVIEW; SYSTEMATIC REVIEW;

CONTRAST MEDIA; DRUG INTERACTIONS; FIBRINOLYTIC AGENTS; HUMANS; IODINE COMPOUNDS; STROKE; THROMBOLYTIC THERAPY;

EID: 75749142731     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1782     Document Type: Review

References (24)

1. Dehmer GJ, Gresalfi N, Daly D, et al. Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents. J Am Coll Cardiol 1995; 25:1069-75
2. Jones CI, Goodall AH. Differential effects of the iodinated contrast agents ioxaglate, iohexol and iodixanol on thrombus formation and fibrinolysis. Thromb Res 2003;112:65-71
3. Pislaru S, Pislaru C, Szilard M, et al. In vivo effects of contrast media on coronary thrombolysis. J Am Coll Cardiol 1998;32:1102-08
4. Carr ME Jr, Carr SL, Merten SR. Effects of ionic and nonionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots. Haemostasis 1995;25:172-81
5. Davidson CJ, Laskey WK, Hermiller JB, et al. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation 2000;101:2172-77
6. Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003:CD000213, update of Cochrane Database Syst Rev 2000:CD000213
7. Warlow C, van Gijn J, Dennis M, et al. Stroke, Practical Management, 3rd ed., Oxford, UK: Blackwell Publishing; 2008:203
8. Scottish Intercollegiate Guidelines Network. Search Filters. Available at: http://www.sign.ac.uk/methodology/filters.html. Accessed September 2006
9. Kmet LM, Lee RC, Cook LS. Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields. Alberta Heritage Foundation for Medical Research; 2004
10. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58
11. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21:1559-73
12. Nabavi DG, Kloska SP, Nam EM, et al. MOSAIC: Multimodal Stroke Assessment using Computed Tomography-novel diagnostic approach for the prediction of infarction size and clinical outcome. Stroke 2002;33: 2819-26
13. Kloska SP, Nabavi DG, Gaus C, et al. Acute stroke assessment with CT: do we need multimodal evaluation? Radiology 2004;233:79-86. Epub 2004 Aug 31
14. Khatri P, Broderick JP, Khoury JC, et al. Microcatheter contrast injections during intra-arterial thrombolysis may increase intracranial hemorrhage risk. Stroke 2008;39:3283-87
15. Davies MJ, Thomas AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53: 363-73. Epub 2008 Sep 4
16. Molina CA, Montaner J, Arenillas JF, et al. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004;35:486-90
17. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32:78-86
18. Saqqur M, Uchino K, Demchuk AM, et al, for the CLOTBUST Investigators. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948-54. Epub 2007 Feb 8
19. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-78
20. Savitz SI, Schlaug G, Caplan L, et al. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 2005;36:1447-51. Epub 2005 Jun 9
21. Alexandrov AV, Burgin WS, Demchuk AM, et al. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001;103:2897-902
22. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004; 35:109-14. Epub 2003 Dec 11
23. Molina CA, Montaner J, Abilleira S, et al. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study. Stroke 2001;32:2821-27
24. Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-87